TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-κB dependent induction of cFLIPL

J.M. Lluis, U. Nachbur, W.D. Cook, I.E. Gentle, D. Moujalled, M. Moulin, W.W.L. Wong, N. Khan, D. Chau, Bernard Callus, J.E. Vince, J. Silke, D.L. Vaux

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)Article number e8620, 9pp
JournalPLoS One
Publication statusPublished - 2010

Cite this